These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 15718352

  • 1. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
    Baier K, Cvirn G, Fritsch P, Köstenberger M, Gallistl S, Leschnik B, Muntean W.
    Pediatr Res; 2005 May; 57(5 Pt 1):685-9. PubMed ID: 15718352
    [Abstract] [Full Text] [Related]

  • 2. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
    Novak M, Schlagenhauf A, Bernhard H, Schweintzger S, Leschnik B, Muntean W.
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):588-92. PubMed ID: 21799400
    [Abstract] [Full Text] [Related]

  • 3. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK, Berry LR, Monagle PT, Andrew M.
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [Abstract] [Full Text] [Related]

  • 4. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA, Cuddy KK, Stafford AR, Fredenburgh JC, Roberts R, Weitz JI.
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [Abstract] [Full Text] [Related]

  • 5. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin.
    Béguin S, Lindhout T, Hemker HC.
    Thromb Haemost; 1989 Feb 28; 61(1):25-9. PubMed ID: 2749591
    [Abstract] [Full Text] [Related]

  • 6. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S, Muntean W, Leis HJ.
    Thromb Haemost; 1995 Oct 28; 74(4):1163-8. PubMed ID: 8560429
    [Abstract] [Full Text] [Related]

  • 7. Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous formation of factor Xa and IIa and on thrombelastometry profiles in cord versus adult blood.
    Cvirn G, Hoerl G, Tafeit E, Heinl N, Wodrig K, Wagner T, Koestenberger M, Juergens G.
    Neonatology; 2011 Oct 28; 100(1):23-31. PubMed ID: 21150227
    [Abstract] [Full Text] [Related]

  • 8. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb 28; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 9. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O, Kristensen HI, Valentin S, Ostergaard P, Wadt J.
    Thromb Haemost; 1993 Sep 01; 70(3):448-53. PubMed ID: 8259547
    [Abstract] [Full Text] [Related]

  • 10. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA, Lormeau JC, Craven S, Dewar L, Anvari N.
    Thromb Haemost; 1994 Dec 01; 72(6):862-8. PubMed ID: 7740455
    [Abstract] [Full Text] [Related]

  • 11. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME, Angchaisuksiri P, Carr SL, Martin EJ.
    Cell Biochem Biophys; 2003 Dec 01; 39(2):89-99. PubMed ID: 14515016
    [Abstract] [Full Text] [Related]

  • 12. Anticoagulant effects of heparin in neonatal plasma.
    Schmidt B, Ofosu FA, Mitchell L, Brooker LA, Andrew M.
    Pediatr Res; 1989 Apr 01; 25(4):405-8. PubMed ID: 2726317
    [Abstract] [Full Text] [Related]

  • 13. The anticoagulant action of recombinant human activated protein C (rhAPC, Drotrecogin alpha activated): comparison between cord and adult plasma.
    Cvirn G, Gallistl S, Koestenberger M, Baier K, Fritsch P, Greilberger J, Jürgens G, Muntean W.
    Thromb Haemost; 2004 May 01; 91(5):912-8. PubMed ID: 15116251
    [Abstract] [Full Text] [Related]

  • 14. Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.
    Koestenberger M, Gallistl S, Cvirn G, Baier K, Leschnik B, Muntean W.
    Thromb Res; 2005 May 01; 115(1-2):135-42. PubMed ID: 15567465
    [Abstract] [Full Text] [Related]

  • 15. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 01; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 16. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F, Piro D, Rossiello MR, Ammollo T, Colucci M.
    Thromb Haemost; 2007 Dec 01; 98(6):1208-14. PubMed ID: 18064315
    [Abstract] [Full Text] [Related]

  • 17. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
    Tanaka KA, Szlam F, Sun HY, Taketomi T, Levy JH.
    Anesth Analg; 2007 Oct 01; 105(4):933-9, table of contents. PubMed ID: 17898368
    [Abstract] [Full Text] [Related]

  • 18. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T, Blezer R, Hemker HC.
    Thromb Haemost; 1990 Nov 30; 64(3):464-8. PubMed ID: 2096492
    [Abstract] [Full Text] [Related]

  • 19. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K, Wijns W, Combes I, Van kerckhoven S, Hoylaerts MF.
    Thromb Haemost; 2007 Sep 30; 98(3):600-13. PubMed ID: 17849049
    [Abstract] [Full Text] [Related]

  • 20. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep 30; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.